甲状腺疾病的细胞与分子生物学 2.0 版。
Cell and Molecular Biology of Thyroid Disorders 2.0.
机构信息
Department of Biomedicine, Pharmacology, Aarhus University, Ole Worms Allé 4, 8000 Aarhus C, Denmark.
Department of Microgravity and Translational Regenerative Medicine, Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
出版信息
Int J Mol Sci. 2021 Feb 17;22(4):1990. doi: 10.3390/ijms22041990.
Abstract
This issue is the second volume of the previous Special Issue, "" [...].
摘要
本期是上一期特刊“[...]”的第二卷。
相似文献
1
Cell and Molecular Biology of Thyroid Disorders 2.0.
Int J Mol Sci. 2021 Feb 17;22(4):1990. doi: 10.3390/ijms22041990.
2
Autoimmune and malignant thyroid diseases.
Horm Metab Res. 2009 Jun;41(6):419-20. doi: 10.1055/s-0029-1220914. Epub 2009 Jun 9.
3
Cell and Molecular Biology of Thyroid Disorders.
Int J Mol Sci. 2019 Jun 13;20(12):2895. doi: 10.3390/ijms20122895.
4
Molecular alterations in hereditary and sporadic thyroid and parathyroid diseases.
Adv Anat Pathol. 2009 Jan;16(1):23-32. doi: 10.1097/PAP.0b013e3181915f7d.
5
Transgenic models for proliferative and hyperfunctional thyroid diseases.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 3:43-6. doi: 10.1055/s-0029-1211683.
6
[Quantitative immunomorphological criteria in the diagnosis of thyroid diseases].
Klin Khir (1962). 1989(12):6-8.
7
Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Mutat Res. 2006 Jul 25;599(1-2):45-57. doi: 10.1016/j.mrfmmm.2006.01.021. Epub 2006 May 15.
8
[Tumors and pseudotumors of the thyroid].
Rev Invest Clin. 1967 Jan-Mar;19(1):27-33.
9
[Sonography in thyroid gland diagnosis].
Schweiz Rundsch Med Prax. 1987 Jun 23;76(26):745-6.
10
Thyroid cancer and other thyroid disorders.
Endocrinol Metab Clin North Am. 2014 Jun;43(2):xiii-xvi. doi: 10.1016/j.ecl.2014.03.001. Epub 2014 Apr 4.
引用本文的文献
1
Multimodal MRI Deep Learning for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer.
Cancers (Basel). 2024 Dec 2;16(23):4042. doi: 10.3390/cancers16234042.
2
Unveiling the Role of Gut Microbiota and Metabolites in Autoimmune Thyroid Diseases: Emerging Perspectives.
Int J Mol Sci. 2024 Oct 10;25(20):10918. doi: 10.3390/ijms252010918.
3
High expression of COL8A1 predicts poor prognosis and promotes EMT in papillary thyroid cancer.
Endocr Connect. 2024 Nov 21;13(12). doi: 10.1530/EC-24-0279. Print 2024 Dec 1.
4
Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score-matched analysis.
Front Endocrinol (Lausanne). 2023 Aug 17;14:1158581. doi: 10.3389/fendo.2023.1158581. eCollection 2023.
本文引用的文献
1
Gene Dosage Affects Thyroid Cancer Histology and Differentiation In Vivo.
Int J Mol Sci. 2020 Dec 22;22(1):25. doi: 10.3390/ijms22010025.
2
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26.
3
New Therapeutic Horizons for Graves' Hyperthyroidism.
Endocr Rev. 2020 Dec 1;41(6):873-84. doi: 10.1210/endrev/bnaa022.
4
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Int J Mol Sci. 2020 Jun 29;21(13):4629. doi: 10.3390/ijms21134629.
5
The Impact of Transcription Factor Prospero Homeobox 1 on the Regulation of Thyroid Cancer Malignancy.
Int J Mol Sci. 2020 May 2;21(9):3220. doi: 10.3390/ijms21093220.
6
Nutritional status and follicular-derived thyroid cancer: An update.
Crit Rev Food Sci Nutr. 2021;61(1):25-59. doi: 10.1080/10408398.2020.1714542. Epub 2020 Jan 30.
7
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein.
Int J Mol Sci. 2020 Jan 21;21(3):702. doi: 10.3390/ijms21030702.
8
Multikinase Inhibitor Treatment in Thyroid Cancer.
Int J Mol Sci. 2019 Dec 18;21(1):10. doi: 10.3390/ijms21010010.
9
Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
Int J Mol Sci. 2019 Nov 10;20(22):5619. doi: 10.3390/ijms20225619.
10
The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.
Int J Mol Sci. 2019 Nov 7;20(22):5564. doi: 10.3390/ijms20225564.
Zotero 插件